Stock Taper
GoodRx Holdings, Inc. provides a platform for consumers to compare prescription prices, access negotiated savings, and utilize healthcare services nationwide, serving individuals, pharmacies, and healthcare providers.

GoodRx provides discounted cash prices for high-cost brand-name drugs like the FDA-approved Wegovy oral GLP-1 weight loss pill, making these medications more affordable and accessible for consumers without insurance or with high deductibles.
| Icon | PRODUCT | Q2-2025 | Q3-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Prescription Transactions Revenue | $143.06M | $127.29M ▼ | $113.69M ▼ | $106.39M ▼ |
![]() | Subscription Revenue | $20.46M | $20.72M ▲ | $24.39M ▲ | $28.51M ▲ |
![]() | Other Revenue | $4.56M | $4.64M ▲ | $3.69M ▼ | $3.88M ▲ |
Overall rating: B-
| PEER | PRICE | |
|---|---|---|
PLSE | $47.57 | COMPARE |
INVA | $20.97 | COMPARE |
IRMD | $87.07 | COMPARE |
AMPH | $22.01 | COMPARE |
HSTM | $29.38 | COMPARE |
COLL | $25.35 | COMPARE |
AHCO | $5.79 | COMPARE |
CTEV | $39.39 | COMPARE |